Advaxis, Inc. insider transactions

What is a Form 4?

Animation: what a Form 4 is, shown with one real example. Sonic Automotive (SAH) reporting owner Paul P. Rusnak bought 13,701 shares at $59.78 on Wednesday, October 7, 2026, transaction code P, an open-market purchase (S is a sale and A is an award from the company). A timeline marks the SEC's two-business-day filing deadline, which ends Friday, October 9. The SEC accepted the Form 4 at 4:33:21 PM ET on October 9, and NexusTrade treats it as public one minute later, at 4:34:21 PM ET. A lamp for NexusTrade's InsiderTrades indicator stays off from the trade date until that moment, then counts one purchase worth 13,701 × $59.78 = $819,045.78. — In this example the shares were bought on Oct 7, 2026, and NexusTrade's InsiderTrades indicator can count the purchase starting at 4:34:21 PM ET on Oct 9, one minute after the SEC accepted the Form 4.

A Form 4 is the SEC filing a company insider, such as an officer, director or 10% owner, uses to report a trade in the company's stock, generally within two business days. The animation follows one real filing as an example: Paul P. Rusnak's purchase of Sonic Automotive (SAH) shares on October 7, 2026.

The same reading applies to every row on this page. The trade date is when the shares changed hands. The available date is when NexusTrade treats the filing as public, and a NexusTrade InsiderTrades indicator counts a purchase (code P) or sale (code S) only from that moment. Code A awards are not counted as purchases.

Recent insider disclosures

This table includes purchases, sales and awards in the public filing record. Awards and open-market purchases are distinct transaction codes. For historical research, use the public availability date to determine when the transaction was knowable.

Read code P as a purchase, S as a sale and A as an award. An award is an acquisition, but it is not an open-market purchase. Open the filing receipt to check the transaction details.

Show the table · 0 rows, 7 columns

Filter rows

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Most recent 90-day source activity, up to 50 rows. No rows means no matching recent records, not no historical activity.

Officers and directors in the directory

Show the table · 20 rows, 3 columns

Filter rows

Scroll sideways to compare all columns. Select a heading to sort.


O'Connor Daniel J.	0001376847	17
BERMAN RICHARD J	0001111620	105
Mauro David J	0001621172	31
Rosenblum Mark J	0001329154	7
APPEL RONI	0001305979	8
Bonstein Sara	0001604019	46
COBB FREDRICK D	0001238703	2
I.B.F. Management Ltd.	0001994849	2
Israel Biotech Fund GP Partners II, L.P.	0001994923	2
Israel Biotech Fund GP Partners, L.P.	0001994922	2
Israel Biotech Fund I, L.P.	0001652458	3
Israel Biotech Fund II, L.P.	0001782947	2
LOMBARDO ANTHONY A	0001235669	3
Mayes, Gregory T.	0001424630	3
MCKEARN THOMAS J	0001022849	4
MOORE THOMAS A	0001200699	1
PATTON JAMES P	0001306152	1
PETIT ROBERT	0001576077	13
ROTHMAN JOHN F	0001238323	2
SIDRANSKY DAVID	0001277161	15

Which transactions qualify for the company tracker

The company strategy uses verified officers and directors with qualifying acquisitions at this issuer. Other reporting owners may appear in source records without becoming strategy signals.

Strategy eligibility is held while filing coverage is unresolved.

Historical follower simulations are separate from these source transactions. They do not establish live trading results.